The Global Health Investment Fund (GHIF)

The Global Health Investment Fund (GHIF) was established to finance the development of new drugs, vaccines and diagnostics for public health challenges that disproportionately burden poor communities. Our investments support late-stage product development and the early commercialization of promising new healthcare technologies that can be affordably delivered in resource-limited settings. GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing, with an average investment target of approximately $10 million per project. Each GHIF project must advance the fund’s social impact objectives and demonstrate the ability to achieve commercial success. Our investments support new or improved interventions for a wide range of neglected infections diseases--such as tuberculosis, malaria, cholera and river blindness--in addition to family planning products and tools to reduce maternal and infant mortality.